Investing Profile

Carole Nuechterlein

VC
Photo of Carole Nuechterlein, Managing Partner at Roche Venture Fund
University of Michigan Network
87 CONNECTIONS
cb
Roche Venture Fund Managing Partner
9
CompanyStageDateRound SizeTotal Raised
Enthera
Series AJan 2021$8M
$46M
Co-investors: Graziano Seghezzi (Soffinova Partners), Margarita Chavez (AbbVie Ventures)
Arch Oncology
Series AAug 2016$86M
$86M
Co-investors: Peter Moldt (Novo Ventures), John McKearn (RiverVest), Jill carroll (SR One)
AveXis
Series DSep 2015$65M
Series CJan 2015$10M
$75M
Co-investors: Jonathan Leff (Deerfield Management)
Lysosomal Therapeutics
Series AFeb 2015$20M
SeedMay 2014$5M
$25M
Co-investors: Reza Halse (RA Capital), Bernard Davitian (Omega Funds), Clay Thorp (Hatteras Venture Partners), Bruce Booth (Atlas Venture)
Alios BioPharma
Series BApr 2014$41M
Series AJun 2009$24M
Series AFeb 2009$8M
$74M
Co-investors: Jack Nielsen (Vivo Capital), Heath Lukatch (Red Tree Venture Capital), Jens Eckstein (Apollo Health Ventures)
Head, Roche Venture Fund F.Hoffmann-La Roche2001 - Present
General Counsel SangStat1998 - 2001
University of Michigan JD